Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | multiple endocrine neoplasia I | No references | |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0361 | 0.034 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0092 | 0.0991 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0042 | 0.0044 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0092 | 0.0991 | 0.1009 |
Chlamydia trachomatis | hypothetical protein | 0.0279 | 0.3129 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0092 | 0.0991 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0361 | 0.034 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0092 | 0.0991 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 0.0991 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 0.5574 | 0.5903 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.0782 | 0.0828 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0092 | 0.0991 | 1 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYX (TS) (TSase) | 0.0279 | 0.3129 | 0.5 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.0692 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0492 | 0.4606 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0066 | 0.0026 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.9442 | 1 |
Echinococcus granulosus | dnaJ subfamily B | 0.0494 | 0.5574 | 0.5885 |
Echinococcus multilocularis | tumor protein p63 | 0.0329 | 0.3689 | 0.388 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.9442 | 1 |
Giardia lamblia | Kinase, PLK | 0.0092 | 0.0991 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0329 | 0.3689 | 0.388 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0361 | 0.0382 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0092 | 0.0991 | 0.1049 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 0.5574 | 0.5885 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0339 | 0.0359 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0048 | 0.0492 | 0.0521 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0339 | 0.2964 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Schistosoma mansoni | kinase | 0.0047 | 0.0476 | 0.0504 |
Mycobacterium ulcerans | FAD-dependent thymidylate synthase | 0.0279 | 0.3129 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0092 | 0.0991 | 0.5 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0066 | 0.0026 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0045 | 0.0462 | 0.4478 |
Wolbachia endosymbiont of Brugia malayi | FAD-dependent thymidylate synthase | 0.0882 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.0991 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0092 | 0.0991 | 0.1009 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0361 | 0.0382 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0339 | 0.2952 |
Trypanosoma brucei | polo-like protein kinase | 0.0092 | 0.0991 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.9442 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0045 | 0.0462 | 0.4478 |
Onchocerca volvulus | 0.0048 | 0.0492 | 0.2347 | |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 0.0991 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.